mRNA-LNP:

M D Faizul Hussain Khan1, Floriane Baudin1, Ayyappasamy Sudalaiyadum Perumal2

  • 1Viral Vectors and Vaccines Bioprocessing Group, Department of Bioengineering, McGill University, Montreal, QC H2X 1Y4, Canada.

Vaccines
|August 28, 2025
PubMed
概括

冷干燥 (溶解) 通过将信使RNA (mRNA) 疫苗转化为干粉来稳定它们,克服了关键的储存和分发挑战. 本综述探讨了冷干燥技术,以提高mRNA疫苗的稳定性和全球可访问性.